Cargando…

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach

Brain inflammation is one of the hallmarks of Alzheimer disease (AD) and a current trend is that inflammatory mediators, particularly cytokines and chemokines, may represent valuable biomarkers for early screening and diagnosis of the disease. Various studies have reported differences in serum level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delaby, Constance, Gabelle, Audrey, Blum, David, Schraen-Maschke, Susanna, Moulinier, Amandine, Boulanghien, Justine, Séverac, Dany, Buée, Luc, Rème, Thierry, Lehmann, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547499/ https://www.ncbi.nlm.nih.gov/pubmed/26379616 http://dx.doi.org/10.3389/fneur.2015.00181

Ejemplares similares

Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023)

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ(1–42) and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
por: Duron, Emmanuelle, et al.
Publicado: (2018)

Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß(1−42), and Tau Proteins in Elderly Patients With Mild Cognitive Impairment
por: Duron, Emmanuelle, et al.
Publicado: (2019)

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
por: Dumurgier, Julien, et al.
Publicado: (2015)

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
por: Colin, Morvane, et al.
Publicado: (2019)

Neurofilaments contribution in clinic: state of the art
por: Delaby, Constance, et al.
Publicado: (2022)

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM(R) Scale
por: Lehmann, Sylvain, et al.
Publicado: (2018)

Association between IgM Anti-Herpes Simplex Virus and Plasma Amyloid-Beta Levels
por: Féart, Catherine, et al.
Publicado: (2011)

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
por: Lehmann, Sylvain, et al.
Publicado: (2014)

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022)

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease
por: Mohaupt, Pablo, et al.
Publicado: (2022)

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
por: Lehmann, Sylvain, et al.
Publicado: (2020)

NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline
por: Delaby, Constance, et al.
Publicado: (2021)

The alternative proteome in neurobiology
por: Mohaupt, Pablo, et al.
Publicado: (2022)

Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies
por: Leroux, Elodie, et al.
Publicado: (2022)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
por: Dauvilliers, Yves A., et al.
Publicado: (2014)

Can the administration of platelet lysates to the brain help treat neurological disorders?
por: Nebie, Ouada, et al.
Publicado: (2022)

Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy
por: Laurent, Cyril, et al.
Publicado: (2017)

Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder
por: Lehmann, Sylvain, et al.
Publicado: (2014)

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid
por: Hirtz, Christophe, et al.
Publicado: (2016)

Early-Life Environment Influence on Late-Onset Alzheimer’s Disease
por: Gauvrit, Thibaut, et al.
Publicado: (2022)

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
por: Barthélemy, Nicolas R., et al.
Publicado: (2020)

A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging
por: Dumurgier, Julien, et al.
Publicado: (2022)

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry
por: Bros, Pauline, et al.
Publicado: (2015)

Association of Plasma Aß Peptides with Blood Pressure in the Elderly
por: Lambert, Jean-Charles, et al.
Publicado: (2011)

Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios
por: Marelli, Cecilia, et al.
Publicado: (2015)

Hepcidin and ferritin levels in restless legs syndrome: a case–control study
por: Chenini, Sofiene, et al.
Publicado: (2020)

The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System?
por: Danigo, Aurore, et al.
Publicado: (2021)

Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases
por: Relaño-Ginès, Aroa, et al.
Publicado: (2013)

Mammalian Brain Ca(2+) Channel Activity Transplanted into Xenopus laevis Oocytes
por: Rousset, Matthieu, et al.
Publicado: (2022)

Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
por: Vingtdeux, Valérie, et al.
Publicado: (2012)

Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models
por: Faldini, Enrico, et al.
Publicado: (2019)

The Lin28/let-7 axis is critical for myelination in the peripheral nervous system
por: Gökbuget, Deniz, et al.
Publicado: (2015)

Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort
por: Hirtz, Christophe, et al.
Publicado: (2023)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Tumors of the peripheral nervous system
por: Harkin, James C., 1926-
Publicado: (1969)

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches
por: Vialaret, Jerome, et al.
Publicado: (2018)

Central Nervous System Responses to Simulated Galactic Cosmic Rays
por: Cekanaviciute, Egle, et al.
Publicado: (2018)

Venda más : optimizando la entrevista de ventas /
por: Moulinier, René
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_0au9rhufantn3om0m9b4pko5k3